These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 4158865)

  • 21. Cytotoxic drug and hormone therapy after adrenalectomy for advanced breast cancer.
    Keating JL; Yonemoto RH; Byron RL
    Surg Gynecol Obstet; 1968 Sep; 127(3):538-42. PubMed ID: 4969618
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hormone-therapy of carcinoma of the breast].
    Villani C; Mazzon I
    Minerva Ginecol; 1981 Jan; 33(1):3-26. PubMed ID: 7017505
    [No Abstract]   [Full Text] [Related]  

  • 23. Adrenalectomy for disseminated breast cancer.
    Garas J; Stravolemos K; Athanasiou E; Fassoulaki A
    Int Surg; 1979; 64(6):55-7. PubMed ID: 263073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenalectomy for disseminated breast cancer.
    Cade S
    Br Med J; 1966 Sep; 2(5514):613-5. PubMed ID: 5917379
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current problems in the therapy of diffuse breast carcinoma].
    Di Pietro S
    Minerva Radiol; 1968 Oct; 13(10):569-73. PubMed ID: 5734810
    [No Abstract]   [Full Text] [Related]  

  • 26. Certain aspects of the medical management of metastatic breast cancer.
    Abeloff MD
    Johns Hopkins Med J; 1974 Feb; 134(2):84-9. PubMed ID: 4811013
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of surgery on the endocrine system in metastasizing breast carcinoma].
    Wilcke O; Oesingmann U
    Dtsch Med Wochenschr; 1969 Jan; 94(2):87-92. PubMed ID: 4882199
    [No Abstract]   [Full Text] [Related]  

  • 28. [The choice of hormone treatment in breast carcinoma].
    Schermuly W
    Radiologe; 1966 Jan; 6(1):12-22. PubMed ID: 4165533
    [No Abstract]   [Full Text] [Related]  

  • 29. [Supplemental hormone treatment of operable breast neoplasms].
    Ehlers PN
    Langenbecks Arch Chir; 1970 Dec; 327(1):407-13. PubMed ID: 5526076
    [No Abstract]   [Full Text] [Related]  

  • 30. The management of advanced breast cancer.
    Hunt PS; Nemoto T
    Med J Aust; 1970 Sep; 2(13):591-4. PubMed ID: 5471114
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotherapy in the treatment of advanced breast cancer.
    Russell IS; Moon WJ
    Med J Aust; 1977 Aug; 2(9):294-6. PubMed ID: 72343
    [No Abstract]   [Full Text] [Related]  

  • 32. Transabdominal bilateral adrenalectomy for metastatic breast carcinoma.
    Benson EA
    Ann R Coll Surg Engl; 1979 Nov; 61(6):452-5. PubMed ID: 91342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal ablation.
    Janelli DE; Monteleone F; Mishrick A; Kashiwabara H
    Int Surg; 1979; 64(4):27-31. PubMed ID: 94043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progress in the treatment of metastasizing mammary carcinoma].
    Nagel GA; Senn HJ; Renner KH
    Schweiz Rundsch Med Prax; 1971 Nov; 60(44):1460-8. PubMed ID: 4946677
    [No Abstract]   [Full Text] [Related]  

  • 35. Estrogen receptors and breast cancer response to adrenalectomy.
    Jensen EV; Block GE; Smith S; Kyser K; DeSombre ER
    Natl Cancer Inst Monogr; 1971 Dec; 34():55-70. PubMed ID: 5140877
    [No Abstract]   [Full Text] [Related]  

  • 36. [Endocrine therapy and chemotherapy of breast cancer].
    Watabe H; Abe H; Ogata T; Kumaoka S; Sakauchi N
    Shujutsu; 1969 Aug; 23(8):998-1005. PubMed ID: 5358430
    [No Abstract]   [Full Text] [Related]  

  • 37. [Medical considerations on the treatment of metastasizing mammary carcinoma (author's transl)].
    Lissner J; Kessler M
    MMW Munch Med Wochenschr; 1975 Jul; 117(29-30):1233-8. PubMed ID: 51474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current concepts in the treatment of advanced breast cancer.
    Gardner B
    Oncology; 1972; 26(2):188-96. PubMed ID: 4115086
    [No Abstract]   [Full Text] [Related]  

  • 39. [Management of inoperable or recurrent breast neoplasms].
    Watanabe H; Kanasugi K; Yamamoto H; Nasawa T; Takatani O
    Rinsho Hoshasen; 1975 Nov; 20(12):1091-8. PubMed ID: 1239582
    [No Abstract]   [Full Text] [Related]  

  • 40. Calusterone (NSC-88536): a poor substitute for fluoxy-mesterone (NSC-12165) in the treatment of advanced breast cancer.
    Falkson G; van Dyk JJ; van Eden EB; van der Merwe AM; FALKSON HC
    Cancer Chemother Rep; 1974; 58(6):939-41. PubMed ID: 4615788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.